The effect of β-cryptoxanthin on bone components in the femoral tissues of aged rats was investigated. β-Cryptoxanthin was isolated from Satsuma mandarin (Citrus unshiu MARC.). β-Cryptoxanthin (5, 10, or 20 μg/100 g body weight) was orally administered once daily for 7 days to aged (50 week old) female rats. The administration of β-cryptoxanthin (10 or 20 μg/100 g body weight) caused a significant increase in calcium content, alkaline phosphatase activity and deoxyribonucleic acid (DNA) content in the femoral-diaphyseal and -metaphyseal tissues. Femoral-diaphyseal calcium content and alkaline phosphatase activity were significantly increased by the dose of 5 μg/100 g body weight. A significant increase in metaphyseal alkaline phosphatase activity was also seen with the dose of 5 μg β-cryptoxanthin/100 g body weight. Moreover, bone tissues were cultured for 48 hr in serum-free Dulbecco's modified Eagle's medium containing either vehicle or β-cryptoxanthin (10-7 or 10-6 M). The presence of β-cryptoxanthin (10-7 or 10-6 M) caused a significant increase in calcium content and alkaline phosphatase activity in the femoral-diaphyseal and -metaphyseal tissues obtained from aged (50 week old) female rats. These increases were completely abolished in the presence of cycloheximide (10-6 M), an inhibitor of protein synthesis. This study demonstrated that β-cryptoxanthin has an anabolic effect on bone components in aged female rats in vivo and in vitro.
No takes yet. Share an insight, caveat, or question.
Uchiyama et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: